Cryo-Save Group N.V. (Euronext: CRYO, `Cryo-Save`, or `the Group`), the leading international stem cell processing and cryo-conservation company and the largest family stem cell bank in Europe announces that all resolutions at today`s extra-ordinary general meeting of shareholders (`EGM`) were passed, and that the EGM has resolved to amend the articles of association and to change the company`s name to Esperite N.V.
The company`s shares currently are listed on Euronext Amsterdam under the ticker symbol "CRYO" and the ISIN code NL0009272137. As a consequence of the name change, as of Friday 4 July 2014 the company`s shares shall trade on Euronext Amsterdam under the symbol ticker symbol "ESP". The ISIN code shall not change and continue to be NL0009272137.
The company`s secondary listing on Euronext Paris will become effective and dealings in the company`s shares will commence on Euronext Paris, at 9:00 a.m. (Paris time) on Monday 7 July 2014, under the symbol ticker symbol "ESP" and ISIN Code NL0009272137.
|Cryo-Save Group||+ 31 (0) 575 548 998|
|Frederic Amar, CEO|
About Cryo-Save (www.cryo-save.com/group)
Cryo-Save, the leading international family stem cell bank, stores more than 260,000 samples from umbilical cord blood and cord tissue. There are already many diseases treatable by the use of stem cells, and the number of treatments will only increase. Cryo-Save has cryopreserved samples from over 70 countries on six continents, with ultra-modern processing and storage facilities in Belgium, Switzerland, Dubai, South Africa and Portugal.
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cryo-Save Group N.V. via GlobeNewswire